Investment Q&A

Q: What is your firm's view of GUD ?

Q: I currently own PLI in my TFSA account at only a 1% weight and in a loss position. I have added some money to my TFSA account so would you be a buyer of PLI or wait for the next quarter report?

Thanks

Q: Hi Guys
I owned bioa and sold it at profit 3 years ago .Ive been watching
ever since thinking of going back in . There is a lot on bid side,but
with a delisting looming would this mean it would not trade at all
do think this co. has any chance at all. or just stay out of the way
Bob

Q: Comments please on the second day of sizeable losses for COV. Hoping to avoid a similar experience I had with a prolonged downward trajectory with CRH. What are your suggestions?
Thank you

Q: could you please give me an update on the conference call with covalon, both the positive and negative.
thanks dave

Q: Thoughts for a 3-5 year hold? Is it more "defensive" than the overall sector bc of the types of drugs they make?

Q: Any idea why Covalon fell 20% today? Thx

Q: Could I please have your opinion on this company as to if it is investable or not. Thank You. JACK

Q: Hi, could you please comment on the earning release, this morning. Thanks

Q: Given Buffet/Dimon's plans to enter the pharma space would you still see an opportunity in McKesson and amerisource bergen regardless for the long term

Q: I have a question about 3151
Is it worth holding onto Viemed? Or should I trim the fat and deploy the money elsewhere?

Q: Hi Peter and Ryan. I took your advice and bought one thousand shares of COV in early December. Thank you for this. In the same unregistered account I have 2000 shares of GUD bought under $6.00 a couple years ago. Would you sell 500 or 1000 GUD and add to COV?

Q: What would be your favourite healthcare stocks in Canada and Us?
Thank you

Q: Any comments regarding the movement of SIS with the marijuana sector I have been noticing a bit of a trend here obviously not to the same extremes.. does it just have to do with the 'healthcare' exposure?

Thanks

Q: Cheers. First of all thanks for recent Avo encouragement. Worked out very well.

What are the consequences to Gud if companies like Amazon get into the pharmaceutical business in a big way? Also there is lots of talk by governments and insurance companies of signing contracts with drug providers where drug costs are lowered by 35-40%. Quebec signed such a contract awhile ago and recent reports suggest the other provinces are also in the process of doing so. I believe this is the area where Jonathan Goodman and his team have their expertise and previous success. I have a 3 year invested interest in Gud and wondering how these events are affecting Guds future potential and even its present share price decline?
Would like to hear your valued thots on this.
Thanks
Terry

Q: Hi Peter, Ryan, and Team,

I manage a TFSA for my daughter-in-law. She holds 165 shares of GUD and is presently down $419. I know that you're still positive on GUD, but she's beginning to lose patience. Would you be OK with selling GUD to buy COV (realizing its size makes it more risky) or perhaps buying XHC (which we can do commission free) to stay in the same sector in an otherwise balanced portfolio?
She's 49 years old and is using her TFSA as forced savings by adding $100 each month. (I invest the $100 in a commission-free ETF by looking at the 'best ones' and invest in the one that's down the most on the day that the $100 appears in her account.)

Thanks in advance for your insight.

Q: i would like your opinion on ph results , thank you

Q: Why did NVO take such a big hit today, is the stock now technically broken? im thinking of selling it, its back to where i bought it. your thoughts on the market action in NVO today please

Q: Hi,
I am thinking to buy one of these.
What would be better buy and why?

Thank you.
Milan

Q: What is going on with Cipher? They seem to be doing everything right (reducing interest expense, producing solid earnings) but the stock is hitting 52 week lows while trading at a very low valuation. Thanks